Published in J Nucl Med Radiat Ther on February 01, 2012
Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys (1997) 4.55
The applications of PET in clinical oncology. J Nucl Med (1991) 3.11
Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose. Int J Radiat Oncol Biol Phys (2004) 2.93
Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys (2005) 2.41
Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology (2004) 2.40
Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG 02.02, HeadSTART): a phase III trial of the Trans-Tasman Radiation Oncology Group. J Clin Oncol (2010) 2.12
Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial. Lancet Oncol (2005) 2.10
Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study. Int J Radiat Oncol Biol Phys (2003) 2.10
Metabolic trapping as a principle of oradiopharmaceutical design: some factors resposible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose. J Nucl Med (1978) 2.07
FDG-PET in radiotherapy treatment planning: Pandora's box? Int J Radiat Oncol Biol Phys (2004) 1.91
Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside. J Nucl Med (2005) 1.85
Variability of gross tumor volume delineation in head-and-neck cancer using CT and PET/CT fusion. Int J Radiat Oncol Biol Phys (2006) 1.79
Hybrid PET-CT simulation for radiation treatment planning in head-and-neck cancers: a brief technical report. Int J Radiat Oncol Biol Phys (2004) 1.68
Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer. BMC Cancer (2005) 1.57
Combined 18F-FDG-PET/CT imaging in radiotherapy target delineation for head-and-neck cancer. Int J Radiat Oncol Biol Phys (2008) 1.53
[18F]Fluoroazomycinarabinofuranoside (18FAZA) and [18F]Fluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors. Nucl Med Biol (2003) 1.36
Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma. Int J Radiat Oncol Biol Phys (2006) 1.32
Image fusion between 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas. Int J Radiat Oncol Biol Phys (2002) 1.23
Kinetic analysis of 3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) in head and neck cancer patients before and early after initiation of chemoradiation therapy. J Nucl Med (2009) 1.22
Intraobserver and interobserver variability in GTV delineation on FDG-PET-CT images of head and neck cancers. Int J Radiat Oncol Biol Phys (2007) 1.20
Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancer. Acta Oncol (2004) 1.20
Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging. J Nucl Med (2004) 1.17
FDG-PET/CT-guided intensity modulated head and neck radiotherapy: a pilot investigation. Head Neck (2005) 1.15
Adaptive biological image-guided IMRT with anatomic and functional imaging in pharyngo-laryngeal tumors: impact on target volume delineation and dose distribution using helical tomotherapy. Radiother Oncol (2007) 1.15
18F-2-deoxy-2-fluoro-D-glucose uptake into human tumor xenografts. Feasibility studies for cancer imaging with positron-emission tomography. Cancer (1991) 1.06
Adaptive functional image-guided IMRT in pharyngo-laryngeal squamous cell carcinoma: is the gain in dose distribution worth the effort? Radiother Oncol (2011) 1.05
18F-FLT PET/CT for early response monitoring and dose escalation in oropharyngeal tumors. J Nucl Med (2010) 1.05
Impact of combined (18)F-FDG PET/CT in head and neck tumours. Br J Cancer (2005) 1.04
Can positron emission tomography (PET) be used to detect subclinical response to cancer therapy? The EC PET Oncology Concerted Action and the EORTC PET Study Group. Eur J Cancer (1995) 1.04
Rational diagnosis of squamous cell carcinoma of the head and neck region: comparative evaluation of CT, MRI, and 18FDG PET. AJR Am J Roentgenol (2005) 1.02
FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma. Radiat Oncol (2008) 1.02
Positron emission tomography in the evaluation of stage III and IV head and neck cancer. Head Neck (2001) 1.00
Utility of FMISO PET in advanced head and neck cancer treated with chemoradiation incorporating a hypoxia-targeting chemotherapy agent. Eur J Nucl Med Mol Imaging (2005) 0.99
Correlation between pretreatment FDG-PET biological target volume and anatomical location of failure after radiation therapy for head and neck cancers. Radiother Oncol (2008) 0.99
Positron emission imaging of head and neck cancer, including thyroid carcinoma. Semin Nucl Med (2004) 0.97
Magnetic resonance imaging staging of nasopharyngeal carcinoma in the head and neck. World J Radiol (2010) 0.96
Diagnostic accuracy of magnetic resonance imaging (MRI) in the assessment of tumor invasion depth in oral/oropharyngeal cancer. Oral Oncol (2011) 0.94
Impact of the type of imaging modality on target volumes delineation and dose distribution in pharyngo-laryngeal squamous cell carcinoma: comparison between pre- and per-treatment studies. Radiother Oncol (2006) 0.93
Staging of head and neck squamous cell cancer with extended-field FDG-PET. Arch Otolaryngol Head Neck Surg (2003) 0.92
[18FDG] PET-CT-based intensity-modulated radiotherapy treatment planning of head and neck cancer. Int J Radiat Oncol Biol Phys (2007) 0.90
FDG PET evaluation of head and neck cancer: value of imaging the thorax. Head Neck (2000) 0.89
Evaluation of the role of 18FDG-PET/CT in radiotherapy target definition in patients with head and neck cancer. Acta Oncol (2008) 0.88
Impact of schedule duration on head and neck radiotherapy: accelerated tumor repopulation versus compensatory mucosal proliferation. Int J Radiat Oncol Biol Phys (2011) 0.87
Impact of positron emission tomography on the initial staging and therapy in locoregional advanced squamous cell carcinoma of the head and neck. Laryngoscope (2003) 0.87
Positron emission tomography in the evaluation of synchronous lung lesions in patients with untreated head and neck cancer. Arch Otolaryngol Head Neck Surg (2002) 0.85
Staging of head and neck tumors: [18F]fluorodeoxyglucose positron emission tomography compared with physical examination and conventional imaging modalities. J Oral Maxillofac Surg (2003) 0.85
Role of 11-C-methionine positron emission tomography for the delineation of the tumor volume in pharyngo-laryngeal squamous cell carcinoma: comparison with FDG-PET and CT. Radiother Oncol (2004) 0.84
A multidisciplinary approach to squamous cell carcinomas of the head and neck: an update. Curr Opin Oncol (2008) 0.84
Impact of whole body positron emission tomography on initial staging and therapy in patients with squamous cell carcinoma of the oral cavity. Oral Oncol (2003) 0.84
The emerging era of personalized therapy in squamous cell carcinoma of the head and neck. Asia Pac J Clin Oncol (2011) 0.82
Evaluation of early response to radiotherapy in head and neck cancer measured with [11C]methionine-positron emission tomography. Radiother Oncol (1999) 0.82
A study on the prognostic evaluation of carbon ion radiotherapy for head and neck adenocarcinoma with C-11 methionine PET. Mol Imaging Biol (2010) 0.81
Challenges in integrating 18FDG PET-CT into radiotherapy planning of head and neck cancer. Indian J Cancer (2010) 0.77
High incidence of chest malignancy detected by FDG PET in patients suspected of recurrent squamous cell carcinoma of the upper aerodigestive tract. J Comput Assist Tomogr (2004) 0.76
What is the best way to contour lung tumors on PET scans? Multiobserver validation of a gradient-based method using a NSCLC digital PET phantom. Int J Radiat Oncol Biol Phys (2011) 1.91
Detecting early to mild glaucomatous damage: a comparison of the multifocal VEP and automated perimetry. Invest Ophthalmol Vis Sci (2004) 1.56
Assessing the value of an optional radiation oncology clinical rotation during the core clerkships in medical school. Int J Radiat Oncol Biol Phys (2012) 1.54
Tumor localization using cone-beam CT reduces setup margins in conventionally fractionated radiotherapy for lung tumors. Int J Radiat Oncol Biol Phys (2009) 1.25
Determining abnormal latencies of multifocal visual evoked potentials: a monocular analysis. Doc Ophthalmol (2004) 1.23
Dual targeting of tumor vasculature: combining Avastin and vascular disrupting agents (CA4P or OXi4503). Anticancer Res (2008) 1.21
Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer. Cell Cycle (2013) 1.14
Efficacy of combined antiangiogenic and vascular disrupting agents in treatment of solid tumors. Int J Radiat Oncol Biol Phys (2004) 1.11
Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme. J Neurooncol (2014) 1.08
Determining abnormal interocular latencies of multifocal visual evoked potentials. Doc Ophthalmol (2004) 1.05
Gastroschisis: sonographic diagnosis, associations, management and outcome. Prenat Diagn (2008) 0.98
Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NFκB target stromal MCT4. Cell Cycle (2013) 0.97
Is above age 45 appropriate for upstaging well-differentiated papillary thyroid cancer? Endocr Pract (2013) 0.97
Endovascular management of carotid blowout. World Neurosurg (2011) 0.96
Physician beliefs and practices for adjuvant and salvage radiation therapy after prostatectomy. Int J Radiat Oncol Biol Phys (2011) 0.96
Detection of evolving injury to the brachial plexus during transaxillary robotic thyroidectomy. Laryngoscope (2011) 0.94
Esophagitis, treatment-related toxicity in non-small cell lung cancer. Rev Recent Clin Trials (2012) 0.93
Measuring preferences for analgesic treatment for cancer pain: how do African-Americans and Whites perform on choice-based conjoint (CBC) analysis experiments? BMC Med Inform Decis Mak (2013) 0.93
Clinical experience transitioning from IMRT to VMAT for head and neck cancer. Med Dosim (2012) 0.93
The variable presentations of anaplastic spindle cell squamous carcinoma associated with tall cell variant of papillary thyroid carcinoma. Thyroid (2011) 0.93
Systematic review of hypofractionated radiation therapy for prostate cancer. Cancer Treat Rev (2013) 0.92
Salivary duct carcinoma: the predominance of apocrine morphology, prevalence of histologic variants, and androgen receptor expression. Am J Surg Pathol (2015) 0.92
Differentiating lymphovascular invasion from retraction artifact on histological specimen of breast carcinoma and their implications on prognosis. J Breast Cancer (2012) 0.90
VEGF-associated tyrosine kinase inhibition increases the tumor response to single and fractionated dose radiotherapy. Int J Radiat Oncol Biol Phys (2006) 0.88
Targeting the tumor blood vessel network to enhance the efficacy of radiation therapy. Semin Radiat Oncol (2003) 0.87
Phase I trial using the proteasome inhibitor bortezomib and concurrent chemoradiotherapy for head-and-neck malignancies. Int J Radiat Oncol Biol Phys (2012) 0.86
Postradiotherapy neck dissection for head and neck squamous cell carcinoma: pattern of pathologic residual carcinoma and prognosis. Head Neck (2009) 0.86
Multimodality education for airway endoscopy skill development. Ann Otol Rhinol Laryngol (2009) 0.84
Intensity-modulated radiation therapy and volumetric-modulated arc therapy for adult craniospinal irradiation--a comparison with traditional techniques. Med Dosim (2012) 0.83
Reduced-dose fractionated stereotactic radiotherapy for acoustic neuromas: maintenance of tumor control with improved hearing preservation. Neurosurgery (2013) 0.82
Yttrium-90 Microsphere Brachytherapy for Liver Metastases From Uveal Melanoma: Clinical Outcomes and the Predictive Value of Fluorodeoxyglucose Positron Emission Tomography. Am J Clin Oncol (2016) 0.82
An approach for online evaluations of dose consequences caused by small rotational setup errors in intracranial stereotactic radiation therapy. Med Phys (2011) 0.81
Evaluating changes in radiation treatment volumes from post-operative to same-day planning MRI in High-grade gliomas. Radiat Oncol (2012) 0.81
Impact of local management on long-term outcomes in Ewing tumors of the pelvis and sacral bones: the University of Florida experience. Int J Radiat Oncol Biol Phys (2008) 0.81
Definitive radiotherapy for ewing tumors of extremities and pelvis: long-term disease control, limb function, and treatment toxicity. Int J Radiat Oncol Biol Phys (2008) 0.80
Malignant sarcomatous transformation of fibrous dysplasia. Head Neck Pathol (2014) 0.79
Long-term clinical and functional outcomes after treatment for localized Ewing's tumor of the lower extremity. Int J Radiat Oncol Biol Phys (2007) 0.79
The impact of stool and gas volume on intrafraction prostate motion in patients undergoing radiotherapy with daily endorectal balloon. Radiother Oncol (2014) 0.79
Parathyroid carcinoma: a rare cause of primary hyperparathyroidism. Ear Nose Throat J (2009) 0.79
Effectiveness of PET/CT in the preoperative evaluation of neck disease. Laryngoscope (2013) 0.79
Dietary recommendations during and after cancer treatment: consistently inconsistent? Nutr Cancer (2013) 0.78
Impact of tumor cell VEGF expression on the in vivo efficacy of vandetanib (ZACTIMA; ZD6474). Anticancer Res (2009) 0.78
Positron emission tomography for neck evaluation following definitive treatment with chemoradiotherapy for locoregionally advanced head and neck squamous cell carcinoma. Rev Recent Clin Trials (2012) 0.78
Orbital Involvement by NUT Midline Carcinoma. Ophthal Plast Reconstr Surg (2015) 0.78
Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients. J Hematol Oncol (2013) 0.77
Impact of VEGF expression on the physiological characteristics of clonal cell lines. In Vivo (2007) 0.77
Optimal image-guidance scenario with cone-beam computed tomography in conventionally fractionated radiotherapy for lung tumors. Am J Clin Oncol (2010) 0.77
Ulcerative gastritis secondary to Epstein-Barr viral infection. Dig Dis Sci (2009) 0.77
25-year follow-up of HIV-positive patients with benign lymphoepithelial cysts of the parotid glands: a retrospective review. Anticancer Res (2013) 0.76
Survival analysis of Hispanics in a cohort of patients with hepatocellular carcinoma. Cancer (2014) 0.76
Reirradiation of head and neck cancer with high-dose-rate brachytherapy: a customizable intraluminal solution for postoperative treatment of tracheal mucosa recurrence. Brachytherapy (2010) 0.76
Reirradiation of recurrent meningioma. J Clin Neurosci (2012) 0.76
Chondrosarcoma of the hyoid bone: case report and review of current management options. Head Neck (2014) 0.75
Use of the anterolateral thigh in cranio-orbitofacial reconstruction. Plast Surg Int (2011) 0.75
Occult nodal metastasis in non-small-cell lung cancer: implications for the radiation oncologist. J Clin Oncol (2012) 0.75
In reply to Franken and Barendsen. Int J Radiat Oncol Biol Phys (2013) 0.75
In reply to Dr. King (Adjuvant radiotherapy after prostatectomy: does waiting for a detectable prostate-specific antigen level make sense?). Int J Radiat Oncol Biol Phys (2011) 0.75
A Rare Case of Carcinoma Cuniculatum Involving the Larynx in Association with a Saccular Cyst. Head Neck Pathol (2015) 0.75
Src-signaling interference impairs the dissemination of blood-borne tumor cells. Cell Tissue Res (2012) 0.75
Laparoscopic management of Peutz-Jeghers syndrome (PJS) presenting with chronic non-ischaemic jejuno-jejunal intussusception in an adolescent girl. BMJ Case Rep (2013) 0.75
Laparoscopic Nissen fundoplication and gastrostomy for a giant hiatal hernia in an infant with situs inversus totalis. BMJ Case Rep (2014) 0.75
In regard to Yeoh et al. Int J Radiat Oncol Biol Phys (2012) 0.75
Optimizing parametrial aperture design utilizing HDR brachytherapy isodose distribution. J Contemp Brachytherapy (2013) 0.75
Impact of a radiation oncology elective on the careers of young physicians: update on a prospective cohort study. Int J Radiat Oncol Biol Phys (2013) 0.75
Microvascular free flap reconstruction of orbitocraniofacial defects. Orbit (2013) 0.75
Novel irradiated axial rotational flap model in the rodent. JAMA Facial Plast Surg (2013) 0.75
Recombinant adeno-associated and adenoviral vectors for the transduction of pancreatic and colon carcinoma. Anticancer Res (2006) 0.75
Persistent non-visualisation of the fetal stomach: diagnostic and prognostic implications. Arch Dis Child Fetal Neonatal Ed (2010) 0.75
Primary Cutaneous CD8+ T-cell Lymphoma, an Indolent and Locally Aggressive Form Mimicking Paronychia. Am J Dermatopathol (2017) 0.75
Tension Pneumocephalus Following Orbital Exenteration. Ophthal Plast Reconstr Surg (2016) 0.75
Dosimetric validation for an automatic brain metastases planning software using single-isocenter dynamic conformal arcsDosimetric validation for an automatic brain metastases planning software using single-isocenter dynamic conformal arcs. J Appl Clin Med Phys (2016) 0.75
Management of aerodigestive tract foreign bodies: innovative teaching concepts. Ann Otol Rhinol Laryngol (2007) 0.75
A radiolucent lesion in the posterior mandible. J Oral Maxillofac Surg (2010) 0.75
Perineural invasion of cutaneous squamous cell carcinoma along the zygomaticotemporal nerve. Ophthal Plast Reconstr Surg (2014) 0.75
Polymorphous hemangioendothelioma in a child with acquired immunodeficiency syndrome (AIDS). Pediatr Blood Cancer (2008) 0.75
From survival to survivorship: late side effects become an issue in high-grade glioma. Expert Rev Neurother (2010) 0.75
Stereotactic radiotherapy for trigeminal schwannomas. Neurosurgery (2012) 0.75
Prospective, randomized, controlled trial using best-selling smoking-cessation book. Ear Nose Throat J (2017) 0.75
Contrast-enhanced ultrasound-guided Sentinel lymph node biopsy of the ocular conjunctiva. Laryngoscope (2014) 0.75